Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20956803 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma
Condition: Lymphoma, Mantle Cell
Interventions: Drug: bortezomib;   Other: clinical observation

Indicates status has not been verified in more than two years